RU2002117294A - APPLICATION OF THE BOOFER FOR PREVENTION OF SKIN INFECTIONS CANDIDA ALBICANS - Google Patents

APPLICATION OF THE BOOFER FOR PREVENTION OF SKIN INFECTIONS CANDIDA ALBICANS

Info

Publication number
RU2002117294A
RU2002117294A RU2002117294/15A RU2002117294A RU2002117294A RU 2002117294 A RU2002117294 A RU 2002117294A RU 2002117294/15 A RU2002117294/15 A RU 2002117294/15A RU 2002117294 A RU2002117294 A RU 2002117294A RU 2002117294 A RU2002117294 A RU 2002117294A
Authority
RU
Russia
Prior art keywords
skin
occlusive material
membrane
pharmaceutically acceptable
use according
Prior art date
Application number
RU2002117294/15A
Other languages
Russian (ru)
Inventor
Бо РУНЕМАН (SE)
Бо РУНЕМАН
Ян ФАЭРГЕМАНН (SE)
Ян ФАЭРГЕМАНН
Олле ЛАРКЕ (SE)
Олле ЛАРКЕ
Original Assignee
Ска Хайджин Продактс Аб (Se)
Ска Хайджин Продактс Аб
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ска Хайджин Продактс Аб (Se), Ска Хайджин Продактс Аб filed Critical Ска Хайджин Продактс Аб (Se)
Publication of RU2002117294A publication Critical patent/RU2002117294A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/46Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404Biocides, antimicrobial agents, antiseptic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Claims (7)

1. Применение фармацевтически приемлемого, нетоксичного и не вызывающего раздражения вещества, способного поддерживать рН в диапазоне 2,0-5,5, для получения кожно-окклюзивного материала или мембранно-окклюзивного материала для слизистых для профилактики раздражения и поражений кожи, вызванных Candida albicans.1. The use of a pharmaceutically acceptable, non-toxic and non-irritating substance capable of maintaining a pH in the range of 2.0-5.5 to obtain a skin-occlusive material or membrane-occlusive material for the mucous membranes to prevent irritation and skin lesions caused by Candida albicans. 2. Применение фармацевтически приемлемого, нетоксичного и не вызывающего раздражения вещества, способного поддерживать рН в диапазоне 2,0-5,5, вместе с фармацевтически приемлемым противогрибковым препаратом, таким как производное имидазола, нистатин и циклопироксоламин, для получения кожно-окклюзивного материала или мембранно-окклюзивного материала для слизистых для профилактики раздражении и поражений кожи, вызванных Candida albicans.2. The use of a pharmaceutically acceptable, non-toxic and non-irritating substance capable of maintaining a pH in the range of 2.0-5.5, together with a pharmaceutically acceptable antifungal drug, such as imidazole derivative, nystatin and cyclopiroxolamine, to obtain a skin-occlusive material or membrane - an exclusive material for the mucous membranes to prevent irritation and skin lesions caused by Candida albicans. 3. Применение по п.1 или 2, где фармацевтически приемлемое, нетоксичное и не вызывающее раздражения буферное вещество представляет собой частично нейтрализованный суперабсорбент.3. The use according to claim 1 or 2, where the pharmaceutically acceptable, non-toxic and non-irritating buffer substance is a partially neutralized superabsorbent. 4. Применение по п.1 или 2, где фармацевтически приемлемое, нетоксичное и не вызывающее раздражения буферное вещество представляет собой буферный раствор соли органической кислоты.4. The use according to claim 1 or 2, where the pharmaceutically acceptable, non-toxic and non-irritating buffer substance is a buffer solution of an organic acid salt. 5. Применение по любому из пп.1-4 для получения кожно-окклюзивного материала или мембранно-окклюзивного материала для слизистых, представляющего собой абсорбирующий материал, такой как пеленки, гигиеническая салфетка или прокладка.5. The use according to any one of claims 1 to 4 for obtaining a skin-occlusive material or a membrane-occlusive material for mucous membranes, which is an absorbent material, such as a diaper, sanitary napkin or panty liner. 6. Применение по любому из пп.1-4 для получения кожно-окклюзивного материала или мембранно-окклюзивного материала для слизистых, представляющего собой раневую повязку, пластырь, хирургическую повязку или подобный материал.6. The use according to any one of claims 1 to 4 for obtaining a skin-occlusive material or membrane-occlusive material for the mucous membranes, which is a wound dressing, patch, surgical dressing or similar material. 7. Применение по любому из пп.1-4 для получения кожно-окклюзивного материала или мембранно-окклюзивного материала для слизистых, представляющего собой перчатки, протез или постоянный катетер.7. The use according to any one of claims 1 to 4 for obtaining a skin-occlusive material or a membrane-occlusive material for mucous membranes, which is a glove, prosthesis or permanent catheter.
RU2002117294/15A 1999-12-02 2000-11-06 APPLICATION OF THE BOOFER FOR PREVENTION OF SKIN INFECTIONS CANDIDA ALBICANS RU2002117294A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9904387A SE521431C2 (en) 1999-12-02 1999-12-02 Use of a pH buffering substance to prevent skin infections caused by Candida Albicans
SE9904387-9 1999-12-02

Publications (1)

Publication Number Publication Date
RU2002117294A true RU2002117294A (en) 2004-01-27

Family

ID=20417954

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2002117294/15A RU2002117294A (en) 1999-12-02 2000-11-06 APPLICATION OF THE BOOFER FOR PREVENTION OF SKIN INFECTIONS CANDIDA ALBICANS

Country Status (13)

Country Link
EP (1) EP1233746A1 (en)
JP (1) JP2003515544A (en)
KR (1) KR20020060249A (en)
AU (1) AU778633B2 (en)
BR (1) BR0016005A (en)
CA (1) CA2392102A1 (en)
CO (1) CO5251413A1 (en)
MX (1) MXPA02005211A (en)
PL (1) PL355410A1 (en)
RU (1) RU2002117294A (en)
SE (1) SE521431C2 (en)
SK (1) SK7882002A3 (en)
WO (1) WO2001039582A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6630152B2 (en) 1999-04-07 2003-10-07 Shen Wei (Usa), Inc. Aloe vera glove and manufacturing method
US6274154B1 (en) 1999-04-07 2001-08-14 Belle L Chou Aloe Vera glove and manufacturing method
EP1354586A1 (en) * 2002-04-20 2003-10-22 Aventis Pharma Deutschland GmbH The use of hydroxpyridone-derivatives in wound healing
US20030204893A1 (en) * 2002-05-02 2003-11-06 Chou Belle L. Elastomeric flexible article and manufacturing method
US9757285B2 (en) 2011-03-07 2017-09-12 Edgewell Personal Care Brands, Llc Absorbent article including a buffer composition
DE102011106046A1 (en) 2011-06-30 2013-01-03 Paul Hartmann Ag Wound Care Product

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3794034A (en) * 1973-02-27 1974-02-26 J Jones Odor reductant body waste pad
PH23760A (en) * 1985-05-15 1989-11-03 Procter & Gamble Disposable absorbent articles
US4842593A (en) * 1987-10-09 1989-06-27 The Procter & Gamble Company Disposable absorbent articles for incontinent individuals
WO1995019190A1 (en) * 1994-01-17 1995-07-20 Carlo Alfredo Graziani Napkin with buffer substance
SE511838C2 (en) * 1997-06-17 1999-12-06 Sca Hygiene Prod Ab Reduction of undesirable side effects when using absorbent articles by means of pH control
AP2000001805A0 (en) * 1997-10-22 2000-06-30 Jens Ponikau Use of antifungal agents for the topical treatment of fungus-induced mucositis.
CA2322461C (en) * 1998-03-12 2007-02-06 The Procter & Gamble Company Proton donating actives in absorbent articles

Also Published As

Publication number Publication date
KR20020060249A (en) 2002-07-16
SK7882002A3 (en) 2002-12-03
SE9904387L (en) 2001-06-03
WO2001039582A1 (en) 2001-06-07
CA2392102A1 (en) 2001-06-07
SE521431C2 (en) 2003-11-04
SE9904387D0 (en) 1999-12-02
MXPA02005211A (en) 2002-12-09
CO5251413A1 (en) 2003-02-28
PL355410A1 (en) 2004-04-19
AU1906301A (en) 2001-06-12
EP1233746A1 (en) 2002-08-28
AU778633B2 (en) 2004-12-16
JP2003515544A (en) 2003-05-07
BR0016005A (en) 2002-07-30

Similar Documents

Publication Publication Date Title
RU2657532C2 (en) Physical method of combating microorganisms
US11191274B2 (en) Biofilm penetrating compositions and methods
US4385632A (en) Germicidal absorbent body
DOP2008000001A (en) SUBSTITUTED OXAZOLIDINONES AND ITS USE
EP3419676A1 (en) Antimicrobial compositions and uses thereof
JPH06509956A (en) extracorporeal incontinence device
ATE324896T1 (en) ANTIMICROBIAL COMPOSITIONS CONTAINING TAUROLIDINE, CITRIC ACID AND SODIUM CITRATE
PT1079806E (en) PREPARATIONS FOR THE APPLICATION OF ANTI-INFLAMMATORY, ESPECIALLY, ANTI-SEPTIC AGENTS AND / OR WOUND HEALING PROMOTION AGENTS, IN THE SUPERIOR AND / OR HEARING RESPIRATORY TRACT
EP1330221A4 (en) Medical compositions, dressings and methods for treating microbial infections of skin lesions
MXPA03000353A (en) Medicaments for chemotherapeutic treatment of disease.
US20220175673A1 (en) Surgical device
RU2002117294A (en) APPLICATION OF THE BOOFER FOR PREVENTION OF SKIN INFECTIONS CANDIDA ALBICANS
DE60018409D1 (en) USE OF ANTISEPTICA FOR THE PREPARATION OF MEDICAMENTS FOR THE PROPHYLAXIS AND THE TREATMENT OF INFECTIONS AND / OR FUNCTIONAL TISSUE FORMATIONS IN THE BODY'S INSECTS
ATE458471T1 (en) FORMULATIONS CONTAINING POVIDONE IODINE FOR THE TREATMENT OF WOUNDS
RU2344837C2 (en) Absorbing article containing skin care agent
ES2312421T3 (en) PHARMACEUTICAL COMPOSITION IN GEL.
ES2693326T3 (en) Device to treat the female urogenital tract
ES2843052T3 (en) Ectoin and ectoine derivatives for use in vulvovaginal conditions
RU61556U1 (en) ENZYME IMMUNOMODULATING ANTIBACTERIAL PERFORATIVE ATRAUMATIC ADHESIVE PLASTER
ITRM960755A1 (en) DISINFECTANT COMPOSITION IN PARTICULAR FOR THE PREVENTION OF DERMA TITI FROM NAPS AND METHOD FOR ITS USE
WO2021074471A1 (en) Disposable antibacterial protector comprising copper wire
JP2008514698A (en) Non-absorbable article and absorbent article for inhibiting production of foreign protein
UA133979U (en) METHOD OF PREVENTION OF DISEASES TRANSMITTED BY THE SEXUAL PATH IN MAN
Shi-liang et al. Burns of special areas
ECSP003844A (en) SUBSTITUTED OXAZOLIDINONES AND ITS USE